Adsorptive depletion of α4 integrinhi- and CX 3CR1hi-expressing proinflammatory monocytes in patients with ulcerative colitis

Digestive Diseases and Sciences

Volumn 55, Issue 7, 2010, Pages 1886-1895

  Takeda, Shin Ichiro ^a   Sato, Toru ^a   Katsuno, Tatsuro ^a   Nakagawa, Tomoo ^a   Noguchi, Yoshiko ^a   Yokosuka, Osamu ^a   Saito, Yasushi ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

4 Integrin; Adsorptive depletion of myeloid leucocytes; CD14 hiCD16 CCR2low monocytes; CD14+CD16+ monocytes; CX3CR1; Ulcerative colitis

Indexed keywords

ALPHA4 INTEGRIN; CHEMOKINE RECEPTOR CX3CR1; CORTICOSTEROID; CD14 ANTIGEN; CHEMOKINE RECEPTOR CXCR3; CXCR3 PROTEIN, HUMAN; FC RECEPTOR; IMMUNOSUPPRESSIVE AGENT;

ADSORPTION; ADULT; ARTICLE; CELL ISOLATION; CELL MATURATION; CLINICAL ARTICLE; FEMALE; FLUORESCENCE ACTIVATED CELL SORTER; GRANULOCYTE; HUMAN; MALE; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ULCERATIVE COLITIS; ADOLESCENT; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; FLOW CYTOMETRY; IMMUNOLOGY; LEUKAPHERESIS; METABOLISM; METHODOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PROBABILITY;

ADOLESCENT; ADSORPTION; ADULT; ANTIGENS, CD14; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; FEMALE; FLOW CYTOMETRY; GRANULOCYTES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTEGRIN ALPHA4; LEUKAPHERESIS; MALE; MIDDLE AGED; MONOCYTES; PROBABILITY; RECEPTORS, CXCR3; RECEPTORS, IGG; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 77954427928     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-0974-2     Document Type: Article

References (57)

1. Allison MC, Dhillon AP, Lewis WG, Pounder RE, eds. Inflammatory Bowel Disease. London: Mosby; 1998:15-95.
2. DC Baumgart SR Carding 2007 Inflammatory bowel disease: cause and immunobiology Lancet 369 1627 1640 10.1016/S0140-6736(07)60750-8 17499605 (Pubitemid 46722636)
3. DC Baumgart WJ Sandborn 2007 Inflammatory bowel disease: clinical aspects and established and evolving therapies Lancet 369 1641 1657 10.1016/S0140-6736(07)60751-X 17499606 (Pubitemid 46722637)
4. RJ Xavier DK Podolsky 2007 Unravelling the pathogenesis of inflammatory bowel disease Nature 448 427 434 10.1038/nature06005 17653185 (Pubitemid 47123518)
5. W Strober I Fuss P Mannon 2007 The fundamental basis of inflammatory bowel disease J Clin Invest 117 514 521 10.1172/JCI30587 17332878 (Pubitemid 46348505)
6. DQ Shih SR Targan 2008 Immunopathogenesis of inflammatory bowel disease World J Gastroenterol 14 390 400 10.3748/wjg.14.390 18200661 (Pubitemid 351320847)
7. T Shimoyama K Sawada N Hiwatashi, et al. 2001 Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study J Clin Apher 16 1 9 10.1002/jca.1000 11309823 (Pubitemid 32374496)
8. T Yamamoto S Umegae T Kitagawa, et al. 2004 Granulocyte and monocyte adsorptive apheresis in the treatment of active distal ulcerative colitis: a prospective, pilot study Aliment Pharmacol Ther 20 783 792 10.1111/j.1365-2036. 2004.02189.x 15379839 (Pubitemid 39319234)
9. E Domenech J Hinojosa M Esteve-Comas, et al. 2004 Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study Aliment Pharmacol Ther 20 1347 1352 10.1111/j.1365-2036.2004.02288.x 15606397 (Pubitemid 40040082)
10. Y Suzuki N Yoshimura AR Saniabadi Y Saito 2004 Selective granulocyte and monocyte adsorptive apheresis as a first-line treatment for steroid naive patients with active ulcerative colitis: a prospective uncontrolled study Dig Dis Sci 49 565 571 10.1023/B:DDAS.0000026299.43792.ae 15185858 (Pubitemid 38992542)
11. H Hanai K Takeuchi T Iida, et al. 2004 Relationship between fecal calprotectin, intestinal inflammation, and peripheral blood neutrophils in patients with active ulcerative colitis Dig Dis Sci 49 1438 1443 10.1023/B:DDAS.0000042243.47279.87 15481316 (Pubitemid 39273619)
12. K Kanke M Nakano H Hiraishi A Terano 2004 Clinical evaluation of granulocyte/monocyte apheresis therapy for active ulcerative colitis Dig Liver Dis 36 811 817 10.1016/j.dld.2004.08.004 15646427 (Pubitemid 41070579)
13. M Naganuma S Funakoshi A Sakuraba, et al. 2004 Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or -dependent ulcerative colitis Inflamm Bowel Dis 10 251 257 10.1097/00054725- 200405000-00012 15290920 (Pubitemid 38618255)
14. A Andoh T Tsujikawa O Inatomi, et al. 2005 Suppression of inflammatory cytokine secretion by granulocyte/monocyte adsorptive apheresis in active ulcerative colitis Ther Apher Dial 9 123 127 10.1111/j.1774-9987.2005.00229.x 15828923 (Pubitemid 40734773)
15. E Cuadrado M Alonso M de Juan P Echaniz J Arenas 2008 Regulatory T cells in patients with inflammatory bowel diseases treated with adacolumn granulocytapheresis World J Gastroenterol 14 1521 1527 10.3748/wjg.14.1521 18330941 (Pubitemid 351460165)
16. Y Takeda N Shiobara AR Saniabadi M Adachi K Hiraishi 2004 Adhesion dependent release of hepatocyte growth factor and interleukin-1 receptor antagonist from human blood granulocytes and monocytes: evidence for the involvement of plasma IgG, complement C3 and beta2 integrin Inflamm Res 53 277 283 10.1007/s00011-004-1253-5 15241561
17. G Waitz S Petermann S Liebe J Emmrich W Ramlow 2008 Reduction of dendritic cells by granulocyte and monocyte adsorption apheresis in patients with ulcerative colitis Dig Dis Sci 53 2507 2515 10.1007/s10620-007-0168-8 18253828
18. H Takeda Y Suzuki Y Takeda, et al. 2008 A multi center study of granulocyte and monocyte adsorption apheresis therapy for ulcerative colitis-clinical efficacy and production of interleukin-1 receptor antagonist J Clin Apher 23 105 110 10.1002/jca.20164 18449931
19. K Sakimura T Omori E Iwashita, et al. 2006 Clinical response is associated with elevated plasma interleukin-1 receptor antagonist during selective granulocyte and monocyte apheresis in patients with ulcerative colitis Dig Dis Sci 51 1525 1531 10.1007/s10620-005-9012-1 16902810 (Pubitemid 44379293)
20. H Hanai F Watanabe M Yamada, et al. 2004 Correlation of serum soluble TNF-alpha receptors I and II levels with disease activity in patients with ulcerative colitis Am J Gastroenterol 99 1532 1538 10.1111/j.1572-0241.2004. 30432.x 15307873 (Pubitemid 39180103)
21. H Hanai T Iida M Yamada, et al. 2006 Effects of adacolumn selective leukocytapheresis on plasma cytokines during active disease in patients with active ulcerative colitis World J Gastroenterol 12 3393 3399 16733857
22. N Kashiwagi K Sugimura H Koiwai, et al. 2002 Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis Dig Dis Sci 47 1334 1341 10.1023/A:1015330816364 12064810 (Pubitemid 34606638)
23. H Aoki K Nakamura Y Yoshimatsu, et al. 2007 Adacolumn selective leukocyte adsorption apheresis in patients with active ulcerative colitis: clinical efficacy, effects on plasma IL-8, and expression of Toll-like receptor 2 on granulocytes Dig Dis Sci 52 1427 1433 10.1007/s10620-006-9406-8 17394078 (Pubitemid 46776491)
24. + T-Cell subsets in patients with ulcerative colitis: modified by selective granulocyte and monocyte adsorption apheresis Dig Dis Sci 52 2725 2731 10.1007/s10620-006-9560-z 17404876 (Pubitemid 47373881)
25. B Passlick D Flieger HW Ziegler-Heitbrock 1989 Identification and characterization of a novel monocyte subpopulation in human peripheral blood Blood 74 2527 2534 2478233
26. ++ monocytes are a major source of TNF J Immunol 168 3536 3542 11907116
27. + blood monocytes: their role in infection and inflammation J Leukoc Biol 81 584 592 10.1189/jlb.0806510 17135573 (Pubitemid 46393535)
28. F Geissmann S Jung DR Littman 2003 Blood monocytes consist of two principal subsets with distinct migratory properties Immunity 19 71 82 10.1016/S1074-7613(03)00174-2 12871640 (Pubitemid 36859902)
29. D Strauss-Ayali SM Conrad DM Mosser 2007 Monocyte subpopulations and their differentiation patterns during infection J Leukoc Biol 82 244 252 10.1189/jlb.0307191 17475785 (Pubitemid 47230633)
30. S Gordon P Taylor 2005 Monocyte and macrophage heterogeneity Nat Rev Immunol 5 953 964 10.1038/nri1733 16322748 (Pubitemid 41746764)
31. ++ monocytes in patients with inflammatory bowel disease Am J Gastroenterol 103 1210 1216 10.1111/j.1572-0241.2007.01714.x 18177452 (Pubitemid 351677962)
32. S Lichtiger DH Present A Kornbluth, et al. 1994 Cyclosporine in severe ulcerative colitis refractory to steroid therapy N Engl J Med 330 1841 1845 10.1056/NEJM199406303302601 8196726 (Pubitemid 24188135)
33. CL Tsou W Peters Y Si, et al. 2007 Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites J Clin Invest 117 902 909 10.1172/JCI29919 17364026 (Pubitemid 46556746)
34. NV Serbina EG Pamer 2006 Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2 Nat Immunol 7 311 317 10.1038/ni1309 16462739
35. AR Saniabadi H Hanai K Takeuchi, et al. 2003 Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes Ther Apher Dial 7 48 59 10.1046/j.1526-0968.2003.00012.x 12921115 (Pubitemid 36648043)
36. AR Saniabadi H Hanai Y Suzuki, et al. 2005 Adacolumn for selective leukocytapheresis as a non-pharmacological treatment for patients with disorders of the immune system: an adjunct or an alternative to drug therapy? J Clin Apher 20 171 184 10.1002/jca.20046 15892107 (Pubitemid 43081867)
37. AR Saniabadi H Hanai K Fukunaga, et al. 2007 Therapeutic leukocytapheresis for inflammatory bowel disease Transfus Apher Sci 37 191 200 10.1016/j.transci.2007.08.003 17974479 (Pubitemid 350186259)
38. + blood monocytes Eur J Immunol 31 48 56 10.1002/1521- 4141(200101)31:1<48::AID-IMMU48>3.0.CO;2-5 11169437 (Pubitemid 32095996)
39. E Grage-Griebenow HD Flad M Ernst M Bzowska J Skrzeczynska J Pryjma 2000 Human MO subsets as defined by expression of CD64 and CD16 differ in phagocytic activity and generation of oxygen intermediates Immunobiology 202 42 50 10879688
40. NV Serbina T Jia TM Hohl EG Pamer 2008 Monocyte-mediated defense against microbial pathogens Annu Rev Immunol 26 421 452 10.1146/annurev.immunol.26. 021607.090326 18303997 (Pubitemid 351600381)
41. + monocytes J Exp Med 197 1701 1707 10.1084/jem.20022156 12810688 (Pubitemid 36745345)
42. L Stievano E Piovan A Amadori 2004 C and CX3C chemokines: cell sources and physiopathological implications Crit Rev Immunol 24 205 228 10.1615/CritRevImmunol.v24.i3.40 15482255 (Pubitemid 39419499)
43. + T cells by mucosal endothelial cell-derived fractalkine in inflammatory bowel disease Gastroenterology 132 139 153 10.1053/j.gastro.2006.10.010 17241867 (Pubitemid 46108734)
44. D Podolsky R Lobb N King, et al. 1993 Attenuation of colitis in the cotton-top tamarin by anti-alpha 4 integrin monoclonal antibody J Clin Invest 92 372 380 10.1172/JCI116575 7686922
45. H Hanai F Watanabe M Yamada, et al. 2004 Adsorptive granulocyte and monocyte apheresis versus prednisolone in patients with corticosteroid-dependent moderately severe ulcerative colitis Digestion 70 36 44 10.1159/000080079 15297776 (Pubitemid 39179238)
46. B Giampaolo P Giuseppe B Michele M Alessandro S Fabrizio C Alfonso 2006 Treatment of active steroid-refractory inflammatory bowel diseases with granulocytapheresis: our experience with a prospective study World J Gastroenterol 12 2201 2204 16610021
47. W Kruis A Dignass E Steinhagen-Thiessen, et al. 2005 Open label trial of granulocyte apheresis suggests therapeutic efficacy in chronically active steroid refractory ulcerative colitis World J Gastroenterol 11 7001 7006 16437606
48. G Bresci G Parisi A Mazzoni F Scatena A Capria 2007 Treatment of patients with acute ulcerative colitis: conventional corticosteroid therapy (MP) versus granulocytapheresis (GMA): a pilot study Dig Liver Dis 39 430 434 10.1016/j.dld.2007.01.001 17379588 (Pubitemid 46506182)
49. V Muratov J Lundahl AK Ulfgren, et al. 2006 Down-regulation of interferon-gamma parallels clinical response to selective leukocyte apheresis in patients with inflammatory bowel disease: a 12 month follow-up study Int J Colorectal Dis 21 493 504 10.1007/s00384-005-0069-2 16538495 (Pubitemid 44111274)
50. L Maiden K Takeuchi R Baur, et al. 2008 Selective white cell apheresis reduces relapse rates in patients with IBD at significant risk of clinical relapse Inflamm Bowel Dis 14 1413 1418 10.1002/ibd.20505 18521900
51. RD Cohen 2005 Treating ulcerative colitis without medications-"look mom, no drugs!" Gastroenterology 128 235 236 10.1053/j.gastro.2004.11.024 15633142 (Pubitemid 40039976)
52. D Schwartz JR Ferguson 2007 Current pharmacologic treatment paradigms for inflammatory bowel disease and the potential role of granulocyte/monocyte apheresis Curr Med Res Opin 23 2715 2728 10.1185/030079907X233241 17894921 (Pubitemid 350146409)
53. MT Abreu S Plevy BE Sands R Weinstein 2007 Selective leukocyte apheresis for the treatment of inflammatory bowel disease J Clin Gastroenterol 41 874 888 10.1097/MCG.0b013e3180479435 18090155 (Pubitemid 350307073)
54. BE Sands WJ Sandborn B Feagan, et al. 2008 A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis Gastroenterology 135 400 409 10.1053/j.gastro.2008.04.023 18602921
55. Y Suzuki N Yoshimura K Fukuda K Shirai Y Saito AR Saniabadi 2006 A retrospective search for predictors of clinical response to selective granulocyte and monocyte apheresis in patients with ulcerative colitis Dig Dis Sci 51 2031 2038 10.1007/s10620-006-9199-9 17004123 (Pubitemid 44832586)
56. H Hanai F Watanabe K Takeuchi, et al. 2003 Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study Clin Gastroenterol Hepatol 1 28 35 10.1053/jcgh.2003.50005 15017514 (Pubitemid 37254469)
57. T Tanaka H Okanobu S Yoshimi, et al. 2008 In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naive patients Dig Liver Dis 40 731 736 10.1016/j.dld.2008.02.012 18387860